Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Irinotecan Hydrochloride. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106632368A reveals a scalable total synthesis route for Irinotecan Hydrochloride, ensuring high purity and supply chain stability for global API manufacturers.
Patent CN102260272B details high-purity Irinotecan synthesis. Eliminates pyridine, improves yield, ensures supply chain reliability for pharmaceutical manufacturers globally.
Patent CN116925093A details a refined irinotecan synthesis using 1-methylpyrrolidine. This method offers cost reduction and scalable manufacturing for pharmaceutical intermediates.